Lessel, Ivana
Chen, Mei-Jan
Lüttgen, Sabine
Arndt, Florian
Fuchs, Sigrid
Meien, Stefanie
Thiele, Holger
Jones, Julie R.
Shaw, Brandon R.
Crossman, David K.
Nürnberg, Peter
Korf, Bruce R.
Kubisch, Christian
Lessel, Davor http://orcid.org/0000-0003-4496-244X
Funding for this research was provided by:
Deutsche Forschungsgemeinschaft (LE4223/1-1)
Article History
Received: 2 November 2019
Accepted: 22 December 2019
First Online: 13 February 2020
Compliance with ethical standards
:
: P Nürnberg is a founder, CEO, and shareholder of ATLAS Biolabs GmbH. ATLAS Biolabs GmbH is a service provider for genomic analyses. The other authors declare that they have no conflict of interest.
: The study has ongoing approval from the University Medical Center Hamburg-Eppendorf Institutional Review Board. The study was performed in accordance with the Declaration of Helsinki protocols.
: All biological samples were obtained following written informed consent from studied individuals or their legal representatives.